Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

NCT00887575 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Sunitinib

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]